Australia · Delayed Price · Currency is AUD Ansell Earnings Call Transcripts
Fiscal Year 2026
-
Double-digit adjusted EPS growth and record cash flow were achieved despite subdued markets, with tariff costs fully offset by price increases and productivity gains. Guidance is maintained, supported by innovation, strong balance sheet, and ongoing share buybacks.
Fiscal Year 2025
-
Strong FY2025 results were driven by organic growth, successful KBU integration, and productivity gains. The board addressed U.S. tariff risks, labor rights, and sustainability, with ongoing board succession and digital transformation initiatives.
-
Delivered strong FY 2025 results with 8% organic sales growth, 10% EBIT growth, and adjusted EPS at the top end of guidance. KBU integration exceeded expectations, and a $200M share buyback is planned. FY 2026 guidance anticipates further growth and tariff mitigation.
-
Double-digit growth in both revenue and profit, with strong performance across all business units and successful integration of KBU driving margin expansion. Guidance for FY25 EPS was raised, supported by robust cash flow, early synergy realization, and effective inflation and tariff mitigation strategies.
Fiscal Year 2024
-
The meeting reviewed FY24 results, highlighted strong progress in productivity and sustainability, and discussed the successful KBU acquisition. Shareholders raised questions on governance, capital raising, and legal matters, with management addressing key risks and future growth plans.
-
Adjusted EPS landed near the top of guidance, driven by record industrial margins and strong cash flow, while healthcare recovered as destocking eased. The KBU acquisition is integrating well, with modest FY25 EPS impact expected, and sustainability leadership was recognized by top agencies.